The Upstream Biopharmaceutical Manufacturing Process Market to Grow Extensively Owing to the Continuous Technological Innovation


Posted February 27, 2019 by sakshiTMR

The Upstream Biopharmaceutical Manufacturing Process Market to Grow Extensively Owing to the Continuous Technological Innovation

 
Transparency Market Research in its new report titled, “Upstream Biopharmaceutical Manufacturing Process Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” provides key insights on the upstream biopharmaceutical manufacturing process market. The new report states that the continuous technological innovation has led to high yield of biopharmaceutical production, as technology aims at faster and easier process of production. Additionally, increase in awareness about application of upstream process in cell therapy, cell banking, antibody production, drug discovery, and recombinant proteins are estimated to expand the growth of the upstream biopharmaceutical manufacturing process market during the forecast period, i.e., 2017 – 2025.
The TMR report has split the global upstream biopharmaceutical manufacturing process market in terms of cell type, process type, product type, end-user, and region. Based on cell type, the global market is divided into bacterial cell and mammalian cell. On the basis of process type, the global upstream biopharmaceutical manufacturing process market is classified into continuous biopharmaceutical process systems and single-use biopharmaceutical process system. According to product type, the global market is segregated into fermenters and bioreactors. In terms of end-user, the global upstream biopharmaceutical manufacturing process market is categorized into contract manufacturing organizations (CMOs), contract research organizations (CROs), biopharmaceutical companies, and academic and research institutes.
On the basis of regional perspective, the global upstream bioprocessing equipment market is split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, North America dominates the global upstream bioprocessing equipment market. The U.S. is the major contributor to the growth of the upstream biopharmaceutical manufacturing process market in the region, as a lot of research activities are carried in this field. The U.S. dominates the use of single use biopharmaceutical manufacturing process systems as compared to continuous biopharmaceutical manufacturing process system. Europe is the second largest market owing to presence of key players.
The TMR report states that the market in Latin America and Middle East & Africa is witnessing sluggish growth, but are expected to project great potential as increasing interest of top players to invest in these regions. The upstream bioprocessing manufacturing process market in Asia Pacific is expected to grow at a rapid pace due to availability of low cost of processing units such as CMOs and CROs. In Asia Pacific, mainly Japan contributes the growth of the market due to contribution of the Japanese biopharmaceutical and food & beverage industry, as per the report. Major players operating in the global upstream biopharmaceutical manufacturing process market are profiled in this report to give a better competitive analysis and these include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Boehringer Ingelheim Pharma GmbH & Co. KG, BiOZEEN, and Katalyst Bio Engineering, among others.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Phone 5186181030
Business Address 90 State Street, Suite 700 Albany, NY 12207
Country United States
Categories Biotech , Research , Science
Tags upstream biopharmaceutical manufacturing process , upstream biopharmaceutical manufacturing process market , upstream biopharmaceutical manufacturing process market size
Last Updated February 27, 2019